This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Lilly Reintegration Scholarship Applications Available For 2013-2014 Academic Year

INDIANAPOLIS, Oct. 1, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that applications for the 2013-2014 school year are now available for the 15 th annual Lilly Reintegration Scholarship. The program provides funding for tuition, books and lab fees to people living with bipolar disorder, schizophrenia and related schizophrenia-spectrum disorders, so they may pursue and achieve their educational and vocational goals. Information is available at

"Since its inception in 1997, the Lilly Reintegration Scholarship has helped hundreds of students to pursue educational opportunities, leading to meaningful jobs and achievement of important life goals," said Bart Peterson, senior vice president, corporate affairs and communications, Lilly. "Despite living with the challenges associated with severe mental illness, these dedicated students are an inspiration. Lilly is proud to celebrate the 15 th anniversary of the program as part of our continuing commitment to the neuroscience community."

An independent judging panel comprised of psychiatric care professionals review applications annually and select scholarship winners. Lilly Reintegration Scholarship recipients have studied at Harvard, Yale and MIT, as well as hundreds of state and private universities, community colleges and trade schools. Recent areas of study include engineering, law, psychiatry, culinary arts, graphic design, social work, physics, education and computer sciences.

"Fifteen years ago, the prospects for higher education and a career for a person battling mental illness were small, as were opportunities to earn an academic scholarship," said Ralph Aquila, M.D., executive director of the Center for Reintegration and chairman of the Lilly Reintegration Scholarship judging panel. "However, data collected from this program over the years show that we have helped many people achieve their goals. On average, our Lilly Reintegration scholars have a 71 percent graduation rate, whereas the nation's average for an incoming freshman class is 55.5 percent.[1]

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,812.19 +19.51 0.11%
S&P 500 2,089.14 +2.55 0.12%
NASDAQ 5,102.8080 +0.33 0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs